Israel Englander Gilead Sciences, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,244,104 shares of GILD stock, worth $110 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,244,104

Previous 360,500 245.11%

Holding current value

$110 Million

Previous $24.7 Million 321.62%

% of portfolio

0.05%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $86.3 Million - $109 Million	-1,296,086 Reduced 51.02%	1,244,104 $104 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $125 Million - $145 Million	1,983,383 Added 356.21%	2,540,190 $174 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $37.2 Million - $45.3 Million	519,402 Added 1388.59%	556,807 $40.8 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $8.06 Million - $9.14 Million	-109,964 Reduced 74.62%	37,405 $3.03 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $28.9 Million - $33 Million	-380,482 Reduced 72.08%	147,369 $11.4 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $214 Million - $244 Million	-2,767,509 Reduced 83.98%	527,851 $43.8 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $4.83 Million - $6.93 Million	-77,474 Reduced 2.3%	3,295,360 $283 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $30.5 Million - $34.8 Million	512,181 Added 17.9%	3,372,834 $208 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $63.6 Million - $71.7 Million	-1,102,159 Reduced 27.81%	2,860,653 $177 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $210 Million - $263 Million	3,627,258 Added 1080.98%	3,962,812 $236 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $4.83 Million - $5.48 Million	74,482 Added 28.53%	335,554 $24.4 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $10.8 Million - $11.6 Million	159,060 Added 155.92%	261,072 $18.2 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $93 Million - $102 Million	-1,465,356 Reduced 93.49%	102,012 $7.03 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $22.1 Million - $25.2 Million	-368,780 Reduced 19.05%	1,567,368 $101 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $103 Million - $118 Million	1,820,911 Added 1580.14%	1,936,148 $113 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $32.3 Million - $40.6 Million	-520,027 Reduced 81.86%	115,237 $7.28 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $41.4 Million - $48 Million	571,854 Added 901.84%	635,264 $48.9 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $78.4 Million - $100 Million	-1,251,286 Reduced 95.18%	63,410 $4.74 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $78.3 Million - $86.2 Million	1,271,277 Added 2927.93%	1,314,696 $85.4 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $135 Million - $149 Million	-2,165,249 Reduced 98.03%	43,419 $2.75 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $108 Million - $121 Million	-1,745,720 Reduced 44.15%	2,208,668 $149 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $22.6 Million - $25.3 Million	-360,778 Reduced 8.36%	3,954,388 $257 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $156 Million - $204 Million	2,576,875 Added 148.24%	4,315,166 $270 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $14.6 Million - $16.2 Million	204,985 Added 13.37%	1,738,291 $134 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $11.1 Million - $13 Million	171,621 Added 12.6%	1,533,306 $109 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $68.5 Million - $83.5 Million	940,568 Added 223.35%	1,361,685 $103 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $10.1 Million - $11.8 Million	141,345 Added 50.52%	421,117 $30.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $20.2 Million - $23.9 Million	279,772	279,772 $22.7 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account